Are hydantoins (phenytoins) human teratogens. 1977

S Shapiro, and D Slone, and S C Hartz, and L Rosenberg, and V Siskind, and R R Monson, and A A Mitchell, and O P Heinonen

UI MeSH Term Description Entries
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006827 Hydantoins Compounds based on imidazolidine dione. Some derivatives are ANTICONVULSANTS. Hydantoin,Imidazolidine-2,4-Diones,Imidazolidine 2,4 Diones
D000014 Abnormalities, Drug-Induced Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment. Drug-Induced Abnormalities,Abnormalities, Drug Induced,Abnormality, Drug-Induced,Drug Induced Abnormalities,Drug-Induced Abnormality

Related Publications

S Shapiro, and D Slone, and S C Hartz, and L Rosenberg, and V Siskind, and R R Monson, and A A Mitchell, and O P Heinonen
January 1981, Archives of neurology,
S Shapiro, and D Slone, and S C Hartz, and L Rosenberg, and V Siskind, and R R Monson, and A A Mitchell, and O P Heinonen
January 2008, Advances in pediatrics,
S Shapiro, and D Slone, and S C Hartz, and L Rosenberg, and V Siskind, and R R Monson, and A A Mitchell, and O P Heinonen
January 2011, Birth defects research. Part A, Clinical and molecular teratology,
S Shapiro, and D Slone, and S C Hartz, and L Rosenberg, and V Siskind, and R R Monson, and A A Mitchell, and O P Heinonen
January 1987, Reproductive toxicology (Elmsford, N.Y.),
S Shapiro, and D Slone, and S C Hartz, and L Rosenberg, and V Siskind, and R R Monson, and A A Mitchell, and O P Heinonen
February 1999, Pediatric research,
S Shapiro, and D Slone, and S C Hartz, and L Rosenberg, and V Siskind, and R R Monson, and A A Mitchell, and O P Heinonen
December 1997, Mutation research,
S Shapiro, and D Slone, and S C Hartz, and L Rosenberg, and V Siskind, and R R Monson, and A A Mitchell, and O P Heinonen
March 2008, Expert opinion on drug safety,
S Shapiro, and D Slone, and S C Hartz, and L Rosenberg, and V Siskind, and R R Monson, and A A Mitchell, and O P Heinonen
June 2015, Journal of pediatric genetics,
S Shapiro, and D Slone, and S C Hartz, and L Rosenberg, and V Siskind, and R R Monson, and A A Mitchell, and O P Heinonen
December 2002, Teratology,
S Shapiro, and D Slone, and S C Hartz, and L Rosenberg, and V Siskind, and R R Monson, and A A Mitchell, and O P Heinonen
January 1976, Journal of clinical pathology. Supplement (Royal College of Pathologists),
Copied contents to your clipboard!